| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.22 | 7e-10 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.19 | 6e-08 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-06 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.24 | 3e-06 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-06 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.24 | 8e-06 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-05 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |